Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Ten-year overall survival of localized lower thoracic and esophagogastric junction carcinoma receiving trimodality therapy: A National Cancer Database analysis.
Authors
Hanna Kakish
University Hospitals Cleveland Medical Center, Cleveland, OH
Hanna Kakish , Nikolas Naleid , Christopher W. Towe , Richard Hoehn , Veronica Mears , J. Eva Selfridge , Melissa Amy Lumish , Madison Conces , David L Bajor , AMR MOHAMED , Lauren E. Henke , Jennifer Anne Dorth , Amit Mahipal , Sakti Chakrabarti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 278)
DOI
10.1200/JCO.2024.42.3_suppl.278
Abstract #
278
Poster Bd #
C16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Determinants of overall survival of young adults with multiple myeloma: A National Cancer Database (NCDB) analysis of years 2004-2017.
First Author: Chakra Pani Chaulagain
Poster
2017 Gastrointestinal Cancers Symposium
Predictors of survival after trimodality therapy for esophageal adenocarcinoma: Analysis from the National Cancer Database.
First Author: Oliver Eng
Poster
2023 ASCO Annual Meeting
State mandatory paid medical leave policies and survival among adults with cancer in the US.
First Author: Justin Michael Barnes
Poster
2023 ASCO Genitourinary Cancers Symposium
Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.
First Author: Javier Puente